SCHEMBL4096758

SCHEMBL4096758

CCCCCCCCCC(=O)Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.56
KMT2A Q03164 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.51
RET P07949 1/20 0.49
TOP2A P11388 2/20 0.49
KDM4E B2RXH2 2/20 0.49
LMNA P02545 2/20 0.49
CYP1A1 P04798 1/20 0.49
ALOX12 P18054 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49
CYP1B1 Q16678 1/20 0.49
EGFR P00533 3/20 0.47
ERBB2 P04626 3/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
APP P05067 1/20 0.46
CA2 P00918 3/20 0.46
MEN1 O00255 1/20 0.46
TTR P02766 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2520075 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL29761141 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL4103854 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL4108565 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL2521078 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL4102835 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL2514966 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL19873151 1.00 ALB (0.56) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL19873140 0.99 KMT2A (0.55) ALBKMT2ASMN1; SMN2RETTOP2A
SCHEMBL2523999 0.95 KMT2A (0.51) ALBKMT2ASMN1; SMN2RETTOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295621-B2 Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant ELC MANAGEMENT LLC (US) 2016-03-29 US disclosed
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent ELC MANAGEMENT LLC 2009-02-05 US disclosed
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant ELC MANAGEMENT LLC 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant SMURF1, CUTA, SMURF2 ALB 1597/4885KMT2A 1425/4885SMN1; SMN2 919/4885
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent SMARCC1, RARG, RARA ALB 2833/4885KMT2A 1387/4885SMN1; SMN2 2191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.